DePuy ASR MDL Update: ASR Implant Developer And DePuy Executives To Be Deposed
Bernstein Liebhard LLP reports that a series of depositions of DePuy Orthopaedic executives as well as one of the developers of the ASR hip replacement system were recently noticed in In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (“MDL No. 2197”), which is currently underway in the U.S. District Court for the Northern District of Ohio. In addition to the deposition of Dr. Thomas Schmalzried, who developed the ASR hip system, several DePuy executives were noticed, including: the Manager of Hip Product Development, the Vice-President of U.S. Sales, the Vice-President of World Marketing, and the Product Director. These depositions are scheduled to take place between March and May 2012.
These upcoming depositions will cover a range of topics including: the design, sale, promotion and marketing of the ASR hip implants, as well as communications relating to complications, post market surveillance and recall of the devices. The DePuy executives have also been asked to produce documents, notes, outlines, presentation materials, testimonies and oral proposals prepared or given to them that reference or relate to the ASR hip systems.
On March 5, 2012, the Honorable David A. Katz, who is presiding over the consolidated litigation, vacated a status conference scheduled for March 15, 2012. According to the order, the conference was vacated because “discovery is proceeding apace which negates the necessity.”
Hip Implant Developer Expected To Testify On A Variety ASR Related Topics
In addition to being credited as one of the main designers and developers of the DePuy ASR hip implant, Dr. Thomas Schmalzried also provided the company with a wide range of consulting services. According to Bloomberg Businessweek, he was paid more than $3 million “in royalty income for intellectual property and/or product development” in 2009 and 2010. Bloomberg reported that in addition to receiving payments for product development, Dr. Schmalzried attended DePuy meetings in support of the ASR products and actively promoted them to his peers. Moreover, a February 28, 2012 article published in the British Medical Journal revealed that Dr. Schmalzried not only assisted DePuy’s marketing efforts, but also authored a paper entitled, “Setting the record straight on metal hypersensitivity,” which was used by DePuy’s sales teams to deter safety concerns raised by other orthopaedic surgeons regarding the ASR hip implants. According to Bloomberg, Dr. Schmalzried is a named defendant in patient lawsuits against DePuy. As reported by Bloomberg, a complaint filed by a California man, alleges that “Dr. Schmalzried and the DePuy representatives assured the orthopedic surgeons during these meetings that the ASR System was safe, was the best product on the market, had an excellent track record and a low and acceptable failure rate.”
The DePuy hip replacement lawyers at Bernstein Liebhard LLP are actively filing cases on behalf of individuals who have been implanted with either or both types of artificial metal-on-metal hip implants manufactured by DePuy. The lawsuits allege that the ASR hip replacement and the metal-on-metal Pinnacle hip replacement systems were defectively designed. Bernstein Liebhard LLP is filing cases in the following actions: In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (“MDL No. 2197”) and In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation (“MDL No. 2244”), which is currently underway in the U.S. District Court for the Northern District of Texas.
Since Johnson & Johnson recalled the ASR hip implants in August 2010, Bernstein Liebhard LLP has provided a wealth of consumer information concerning the ASR hip systems on its website, www.consumerinjurylawyers.com. Those who received a DePuy ASR hip implant and have experienced hip replacement pain or had to undergo revision surgery may be entitled to compensation for medical bills, pain and suffering, lost wages and other injuries.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.
Bernstein Liebhard LLP 10 East 40th Street New York, New York 10016 (877) 779-1414
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.